The concept of spondyloarthritis: Where are we now?

Best Practice and Research: Clinical Rheumatology

Volumn 28, Issue 5, 2014, Pages 663-672

  Garg, Neha ^a   Van Den Bosch, Filip ^b   Deodhar, Atul ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Ankylosing spondylitis; ASAS classification criteria; Axial spondyloarthritis; Non radiographic axial spondyloarthritis

Indexed keywords

ANKYLOSIS; ARTICLE; DISEASE CLASSIFICATION; EVOLUTION; HUMAN; MEDICAL HISTORY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SPONDYLARTHRITIS; CLASSIFICATION;

HUMANS; SPONDYLARTHRITIS;

EID: 84927947266     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2014.10.007     Document Type: Review

References (47)

1. Van der Linden S, Valkenburg HA, de Jongh BM, et al. The risk of developing ankylosing spondylitis in HLAeB27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27: 241-9.
2. Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population in Tromsø, northern Norway. Ann Rheum Dis 1985;44:359-67.
3. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLAeB27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
4. Saraux A, Guedes C, Allain J, et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. J Rheumatol 1999;26:2622-7.
5. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58(1). 15-25.
6. Poddubnyy D, Rudwaleit M. Early spondyloarthritis. Rheum Dis Clin North Am 2012 May;38(2):387-403.
7. Reville JD, Witter JP, Weisman MA. The prevalence of axial spondyloarthritis in the United States: estimates from the U.S. national health and nutrition examination survey, 2009-10. Arthritis Care Res (Hoboken) 2012 Jun;64(6):905-10.
8. Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 1981;32(1):61-6.
9. Khan MA. Update on spondyloarthropathies. Ann Intern. Med 2002;136:896-907.
10. Raymond P. Les maladies de nosanc eancetres a l'age de la pietre (The diseases of our ancestors in stone age). Aeschlape 1912;2:121.
11. Sydenham T. Medical observations concerning the history and cure of acute diseases. translated by RG Latham. London: The Sydenham Society; 1848. p. 254.
12. Bennett PH, Burch TA. Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica Foundation; 1968. p. 305.
13. Moll JM, Haslock I, Macrae IF, et al. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Med (Baltimore) 1974;53:343-64.
14. Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978;21:619-33.
15. Calin A, Porta J, Fries JF, et al. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-4.
16. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
17. Seiper J, van der Heijde D, Landewe R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from Assessment of Spondyloarthritis International Society (ASAS). Ann Rheum Dis 2009; 68(6):784-8.
18. Dougados M, van der Linden S, Juhlin R, et al. The European Spondyloarthritis Study Group preliminary criteria for the classification of Spondyloarthropathy. Arthritis Rheum 1991;34(1):1218-27.
19. Amor B, Dougados M, Mijiyawa M. Criteria for classification of spondyloarthropathies. Rev Rhum Osteoartic 1990;57: 85-9.
20. Zeidler H, Amor B. The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral arthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. Ann Rheum Dis 2011;70(1):1-3.
21. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year followup. J Rheumatol 1988;15:1109-14.
22. Rudwaleit M, Khan M, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis. Do we need new criteria? Arth Rheum 2005;52(4):1000-8.
23. Oostveen J, Prevo R, den Boer J, et al. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography: a prospective, longitudinal study. J Rheumatol 1999;26:1953-8.
24. Ahlstrom H, Feltelius N, Nyman R, et al. Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum 1990;33:1763-9.
25. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
26. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondyloarthritis: results from the German Spondyloarthritis inception cohort. Arthritis Rheum 2009 Mar;60(3):717-27.
27. Gofton JP, Lawrence JS, Bennett PH, et al. Sacroiliitis in eight populations. Ann Rheum Dis 1966;25:528-33.
28. Van Tubergen A, Heuft-Dorenbosch L, Schulpen G, et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis 2003;62:519-25.
29. Rudwaleit M, Listing J, Marker-Hermann E, et al. Spinal mobility in early ankylosing spondylitis (AS) and in axial SpA without definite radiographic sacroiliitis. Ann Rheum Dis 2004;63(Suppl. 1):400.
30. Sadowska-Wroblewska M, Filipowicz A, Garwolinska H, et al. Clinical signs and symptoms useful in the early diagnosis of ankylosing spondylitis. Clin Rheumatol 1983;2:37-43.
31. Thomas E, Silman AJ, Papageorgiou AC, et al. Association between measures of spinal mobility and low back pain. Spine 1998;23:343-7.
32. Rudwaleit M, Metter A, Listing J, et al. Clinical parameters in the differentiation of inflammatory back pain from noninflammatory back pain. Ann Rheum Dis 2002;61(Suppl. 1):57.
33. Rudwaleit M, Landewé R, van der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770-6.
34. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68: 777-83.
35. Rudwaleit M, van der Heijde D, Landewé R, et al. The assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70(1):25-31.
36. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009;68: 1520-7.
37. Rudwaleit M. New approaches to diagnosis and classification of axial and peripheral spondyloarthritis. Curr Opin Rheumatol 2010;22:375-80.
38. Bennett AN, McGonagle D, O'connor P, et al. Severity of baseline magnetic resonance imaging e evidence sacroiliitis and HLA B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis in eight years. Arthritis Rheum 2008;58(11):3413-8.
39. Deodhar A, Reveille J, van den Bosch F, et al. The concept of axial spondyloarthritis: SPARTAN and ASAS joint Statement in response to FDA's comments and concerns". Arthritis & Rheumatol 2014 Oct;66(10):2649-56.
40. Paramarta JE, De Rycke L, Heijda TF, et al. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritispatients without ankylosing spondylitis or psoriatic arthritis. Ann Rheum Dis 2013 Nov;72(11):1793-9.
41. Lipton S, Deodhar A. The new ASAS classification criteria for axial and peripheral spondyloarthritis: promises and pitfalls. Int J Clin Rheumatol 2012;7(6).
42. Raychaudhuri SP, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 2014; 48-49. 128-133.
43. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54(8):2665-73.
44. Taylor WJ, Robinson PC. Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis. Curr Rheumatol Rep 2013 Apr;15(4):317.
45. Helliwell PS, Mease PJ, FitzGerald O, et al. Peripheral spondyloarthritis and psoriatic arthritis; overlaps and distinctions: a report from the GRAPPA 2012 annual meeting. J Rheumatol 2013 Aug;40(8):1446-9.
46. Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis. Arthritis Rheum 2010;62(5):1298-307.
47. van Vollenhoven RF. Nat Rev Rheumatol 2011;7:205-15.